NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 179 filers reported holding NOVAVAX INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $176,000 | -69.1% | 320,289 | +3.6% | 0.00% | -100.0% |
Q4 2018 | $569,000 | +71.9% | 309,022 | +96.3% | 0.00% | 0.0% |
Q1 2018 | $331,000 | +794.6% | 157,407 | +426.6% | 0.00% | – |
Q4 2017 | $37,000 | +76.2% | 29,890 | +61.2% | 0.00% | – |
Q3 2017 | $21,000 | +5.0% | 18,540 | +5.1% | 0.00% | – |
Q2 2017 | $20,000 | -16.7% | 17,636 | -4.7% | 0.00% | – |
Q1 2017 | $24,000 | +14.3% | 18,502 | +12.1% | 0.00% | – |
Q4 2016 | $21,000 | -97.8% | 16,500 | -96.4% | 0.00% | -100.0% |
Q3 2016 | $955,000 | +86.9% | 459,000 | +552.7% | 0.01% | +66.7% |
Q2 2016 | $511,000 | +265.0% | 70,322 | +160.4% | 0.00% | – |
Q1 2016 | $140,000 | -24.3% | 27,007 | +22.8% | 0.00% | -100.0% |
Q4 2015 | $185,000 | -78.5% | 22,000 | -81.9% | 0.00% | -80.0% |
Q3 2015 | $860,000 | +0.6% | 121,733 | +58.6% | 0.01% | -16.7% |
Q2 2015 | $855,000 | +227.6% | 76,735 | +143.6% | 0.01% | +200.0% |
Q1 2015 | $261,000 | +16.5% | 31,500 | -16.6% | 0.00% | 0.0% |
Q4 2014 | $224,000 | +339.2% | 37,769 | +241.2% | 0.00% | +100.0% |
Q2 2014 | $51,000 | – | 11,068 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |